Nukkleus Inc. Files 8-K: Other Event Reported

TL;DR

NUKK filed an 8-K for an 'Other Event' on Nov 25, 2024. Details TBD.

AI Summary

Nukkleus Inc. filed an 8-K on November 25, 2024, reporting an "Other Event." The filing does not contain specific details about the event, dollar amounts, or dates beyond the filing date itself. The company is incorporated in Delaware and its principal executive offices are located in Jersey City, New Jersey.

Why It Matters

This filing indicates a material event has occurred for Nukkleus Inc., but the lack of detail requires further investigation to understand its implications.

Risk Assessment

Risk Level: medium — The filing is an 8-K for an 'Other Event' without specific details, creating uncertainty about the nature and impact of the event.

Key Players & Entities

• Nukkleus Inc. (company) — Registrant
• November 25, 2024 (date) — Filing Date
• Delaware (jurisdiction) — State of Incorporation
• Jersey City, New Jersey (location) — Principal Executive Offices
• Brilliant Acquisition Corp (company) — Former Company Name

FAQ

Key Financial Figures

• $0.0001 — nge on which registered Common Stock, $0.0001 par value per share NUKK The Nasdaq
• $11.50 — sable for one Share of Common Stock for $11.50 per share NUKKW The Nasdaq Stock Ma

Filing Documents

• ea0222386-8k_nukkleus.htm (8-K) — 36KB
• 0001213900-24-101836.txt ( ) — 249KB
• nukk-20241125.xsd (EX-101.SCH) — 4KB
• nukk-20241125_def.xml (EX-101.DEF) — 26KB
• nukk-20241125_lab.xml (EX-101.LAB) — 36KB
• nukk-20241125_pre.xml (EX-101.PRE) — 25KB
• ea0222386-8k_nukkleus_htm.xml (XML) — 6KB

From the Filing

UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 25, 2024 NUKKLEUS INC. (Exact name of registrant as specified in its charter) Delaware 001-39341 38-3912845 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification Number) 525 Washington Blvd. Jersey (Address of principal executive offices) 212 - 791-4663 (Registrant's telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.0001 par value per share NUKK The Nasdaq Stock Market LLC Warrants, each warrant exercisable for one Share of Common Stock for $11.50 per share NUKKW The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 8.01. Other Events. On October 24, 2024, Nukkleus Inc. (the "Company") completed a one-for-eight reverse stock split of its common stock. In connection with the approval of the reverse stock split, the Company agreed that no fractional shares will be issued in connection with the reverse stock split and that it would issue one full share of the post-reverse stock split common stock to any stockholder who would have been entitled to receive a fractional share as a result of the process. On October 31, 2024, the Company received notice from DTCC on behalf of the brokerage firms that hold the shares of Company common stock held in "street name" that in connection with the foregoing rounding of shares the Company would need to issue 182,004 shares of common stock. The Company does not believe the number of shares being requested is correct based on the historical number of shareholders of its common stock and is aware of similar occurrences in recent months for other companies completing a reverse stock split. As such, the Company has begun an inquiry into the calculations set forth in the request. During the pendency of this inquiry, the Company does not intend to issue any shares in connection with the fractional shares being requested. The Company may face potential liability for its failure to issue the shares of common stock if it is determined that it is required to issue such shares. 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NUKKLEUS INC. Date: November 25, 2024 By: /s/ Menachem Shalom Name: Menachem Shalom Title: Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR